PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
Wells Fargo analyst Mohit Bansal notes that PTAB has instituted Merck's (MRK) patent grant review against Halozyme Therapeutics (HALO) MDASE patents. This patent is one of the patents Merck is fighting against Halozyme. The firm believes this likely reduces the probability of Halozyme prevailing in this case and weakens the bull argument. Wells has an Equal Weight on Halozyme with a price target of $65 on the shares.
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders' Hot Stocks on TipRanks >>
Read More on HALO:
Disclaimer & DisclosureReport an Issue
Merck granted review of Halozyme patent claims by PTAB
Halozyme's Strategic Positioning and Market Potential Drive Buy Rating
Halozyme announces EC approval of Bristol Myers' Opdivo developed with Enhanze
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
Halozyme downgraded to Equal Weight from Overweight at Morgan Stanley
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Top Dividend Stocks To Consider In June 2025
Over the last 7 days, the United States market has risen by 1.4%, contributing to a 12% increase over the past year, with earnings forecasted to grow by 15% annually. In this environment of growth and optimism, selecting dividend stocks that offer consistent income and potential for capital appreciation can be a strategic way to enhance an investment portfolio. Name Dividend Yield Dividend Rating Valley National Bancorp (VLY) 5.07% ★★★★★☆ Universal (UVV) 5.43% ★★★★★★ Southside Bancshares (SBSI) 5.17% ★★★★★☆ First Interstate BancSystem (FIBK) 6.90% ★★★★★★ Ennis (EBF) 5.41% ★★★★★★ Dillard's (DDS) 6.51% ★★★★★★ Credicorp (BAP) 5.18% ★★★★★☆ CompX International (CIX) 5.03% ★★★★★★ Columbia Banking System (COLB) 6.24% ★★★★★★ Chevron (CVX) 4.98% ★★★★★★ Click here to see the full list of 150 stocks from our Top US Dividend Stocks screener. We'll examine a selection from our screener results. Simply Wall St Dividend Rating: ★★★★★☆ Overview: The Hershey Company, along with its subsidiaries, manufactures and sells confectionery products and pantry items both in the United States and internationally, with a market cap of $33.04 billion. Operations: Hershey's revenue is primarily derived from its North America Confectionery segment at $8.71 billion, followed by North America Salty Snacks at $1.14 billion, and International operations contributing $905.10 million. Dividend Yield: 3.4% Hershey maintains a sustainable dividend payout with a 67.4% earnings coverage and 61% cash flow coverage, ensuring stability and reliability over the past decade. Despite trading below estimated fair value, its dividend yield of 3.39% is lower than the top US market payers. Recent board changes and product launches like HERSHEY'S Milk Chocolate with Caramel may support future growth, though Q1 earnings showed decreased sales and income compared to last year at US$2.81 billion and US$224.2 million respectively. Delve into the full analysis dividend report here for a deeper understanding of Hershey. Insights from our recent valuation report point to the potential undervaluation of Hershey shares in the market. Simply Wall St Dividend Rating: ★★★★★☆ Overview: Merck & Co., Inc. is a global healthcare company with operations spanning pharmaceuticals, vaccines, and animal health, and has a market cap of approximately $193.70 billion. Operations: Merck & Co., Inc. generates revenue primarily through its Pharmaceutical segment, which accounts for $57.03 billion, and its Animal Health segment, contributing $5.95 billion. Dividend Yield: 4.1% Merck's dividend is well-covered with a payout ratio of 45.3% and cash payout ratio of 47.7%, indicating sustainability and reliability over the past decade. Although its 4.14% yield is below top-tier US dividend payers, Merck trades at a significant discount to estimated fair value, suggesting potential for capital appreciation. Recent M&A discussions to acquire MoonLake Immunotherapeutics for over US$3 billion highlight efforts to bolster Merck's drug pipeline as Keytruda approaches patent expiration. Click here and access our complete dividend analysis report to understand the dynamics of Merck. According our valuation report, there's an indication that Merck's share price might be on the cheaper side. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Teekay Tankers Ltd. offers marine transportation services to the oil industry both in Bermuda and internationally, with a market cap of approximately $1.53 billion. Operations: Teekay Tankers Ltd. generates its revenue primarily from its Tankers segment, which accounts for $970.44 million, and its Marine Services and Other segment, contributing $122.25 million. Dividend Yield: 4.4% Teekay Tankers' dividend is supported by a low payout ratio of 31.3% and cash payout ratio of 21.5%, yet its history shows volatility with inconsistent growth over the past decade. Despite trading at 85.8% below estimated fair value, recent revenue and net income declines highlight challenges, though a special US$1.00 per share dividend was announced alongside a regular US$0.25 per share quarterly dividend, reflecting mixed signals for income-focused investors. Take a closer look at Teekay Tankers' potential here in our dividend report. Our valuation report here indicates Teekay Tankers may be undervalued. Click here to access our complete index of 150 Top US Dividend Stocks. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include HSY MRK and TNK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Five Below price target raised to $128 from $90 at Telsey Advisory
Telsey Advisory analyst Joseph Feldman raised the firm's price target on Five Below (FIVE) to $128 from $90 and keeps a Market Perform rating on the shares. The firm is encouraged by the company's progress in Q1 and have a more constructive view on the stock, but notes visibility remains clouded, especially int he second half of the year due to changes in merchandising, adjustments to pricing, and the impact of tariffs, the analyst tells investors. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on FIVE: Disclaimer & DisclosureReport an Issue Morning Movers: Brown-Forman plummets following fourth quarter results Uber Eats, Five Below announce delivery partnership Five Below price target raised to $160 from $110 at UBS Five Below price target raised to $128 from $112 at Truist Five Below price target raised to $110 from $98 at Evercore ISI Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
Lianhe Sowell enters sales agreement for 500 Painting Robots
Lianhe Sowell (LHSW) International entered into sales agreements with seven equipment sales agents for sales of 500 Nine-Axis Linkage Spray Painting Robots with full delivery estimated to be completed by Q1 2026. Total sales amount of the 500 unit order is approximately RMB200M. The sales of the Painting Robots will help Lianhe Sowell grow as a pioneer in intelligent painting robotics in China's vehicle repair and maintenance industry, and underscores its dedication to advancing industrial automation through innovative, high-efficiency solutions. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on LHSW: Disclaimer & DisclosureReport an Issue Lianhe Sowell Secures Investment for Robotics R&D and Manufacturing Expansion Lianhe Sowell receives LOI for investment from large investment fund Opening Day: Pinnacle Food Group makes public debut Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
